• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2017 Fiscal Year Final Research Report

Unveiling the Pathological Mechanisms and Developing New Treatment of Parkinsons Disease Caused by GBA1 Mutations

Research Project

  • PDF
Project/Area Number 15H02540
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionKyoto University

Principal Investigator

Takahashi Ryosuke  京都大学, 医学研究科, 教授 (90216771)

Co-Investigator(Kenkyū-buntansha) 木下 政人  京都大学, 農学研究科, 助教 (60263125)
秋山 央子  国立研究開発法人理化学研究所, 脳科学総合研究センター, 研究員 (80623462)
Co-Investigator(Renkei-kenkyūsha) YAMAKADO Hodaka  京都大学, 大学院医学研究科, 助教 (10378771)
UEMURA Norihito  京都大学, 大学院医学研究科, 特定助教 (90749045)
Research Collaborator Ikuno Masashi  京都大学, 大学院医学研究科, 医員
Nakanishi Etsuro  京都大学, 大学院医学研究科, 医員
Project Period (FY) 2015-04-01 – 2018-03-31
Keywordsパーキンソン病 / αシヌクレイン / 脂質 / GBA1 / メダカ / マウス
Outline of Final Research Achievements

We generated GBA2 and GBA3 knockout medaka by CRISPR/Cas9 system and crossed them with GBA1 knockout medaka. The analysis of the double and triple knockout medaka revealed that neither GBA2 nor GBA3 contributes to the pathophysiology in the central nervous system of GBA1 knockout medaka. However, we revealed the novel roles of GBA1 and GBA2 on the metabolism of cholesterol derivatives. The analysis of α-syn BAC Tg;GBA+/- mice revealed accumulation of phosphorylated α-syn in their brains and dopaminergic neuronal loss in the substantia nigra in an age-dependent manner. The low expression of mitochondrial complex I and accumulation of glucosylsphingosine may be associated with their pathophysiology.

Free Research Field

臨床神経学

URL: 

Published: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi